therapeutics News and Research

RSS

Discovery Park Ventures Expands Fund to £3m to Invest in More Innovative Science and Technology Start-Ups

Discovery Park Ventures (DPV) announces the expansion of its early-stage life science fund from £1m to £3m, in order to capitalise on exciting investment opportunities and support its existing portfolio.

5 Dec 2023

Researchers Redesign Future mRNA Therapeutics to Prevent Potentially Harmful Immune Responses

Researchers have discovered that misreading of therapeutic mRNAs by the cell’s decoding machinery can cause an unintended immune response in the body.

5 Dec 2023

New Method Allows Scientists to Observe Multiple Signals in Living Cells

Living cells are bombarded with many kinds of incoming molecular signal that influence their behavior.

29 Nov 2023

FLSHclust Unveils 188 Novel CRISPR-Associated Gene Modules

Employing a groundbreaking algorithm named FLSHclust (“flash clust”), scientists have unearthed 188 uncommon and previously undiscovered CRISPR-associated gene modules, among billions of protein sequences. This includes the identification of a novel type VII CRISPR-Cas system.

24 Nov 2023

Wilmot Researchers Uncover a "Genomic Tug of War" That Influences Decitabine's Effectiveness

Some patients with myelodysplastic syndromes, like acute myeloid leukemia, benefit from a chemotherapy drug called decitabine that stunts cancer growth. But many others are resistant to decatibine's effects or become resistant over time.

17 Nov 2023

New Drug-Like Molecule Enhances Mitophagy, Protects Against Neurodegeneration

Having healthy mitochondria, the organelles that produce energy in all our cells, usually portends a long healthy life whether in humans or in C. elegans, a tiny, short-lived nematode worm often used to study the aging process.

14 Nov 2023

Scientists Identify 4,749 Gene Clusters Linked to Cancer Prognosis

Researchers at the Mount Sinai Center for Transformative Disease Modeling have released a groundbreaking study identifying 4,749 key gene clusters, termed "prognostic modules," that significantly influence the progression of 32 different types of cancer.

14 Nov 2023

Researchers Develop Novel Antifungal Drug with Potential to Save Lives

Scientists at the University of Illinois Urbana-Champaign, in collaboration with researchers at the University of Wisconsin-Madison, have developed a novel antifungal molecule.

9 Nov 2023

Illinois Tech Grows Research Footprint, Securing Prime Space at TCC’s Fulton Labs

Illinois Institute of Technology (Illinois Tech) has leased approximately 34,295 square feet in Trammell Crow Company’s (TCC) Fulton Labs innovation hub, announced today by the Chicago office of TCC, a global real estate developer.

9 Nov 2023

Nucleotide Metabolite Controls DNA Repair and Cancer Sensitivity

Scientists have unraveled the mechanism by which a particular metabolite regulates DNA repair activity and the susceptibility of tissues to cancer treatment.

3 Nov 2023

DNA-Origami Nanoengine Performing Pulsing Movements

An international team of scientists has just invented a revolutionary form of DNA nano-engine.

20 Oct 2023

Creating a DNA Color Code With 16 Million Colors

Researchers at the University of Vienna have achieved a remarkable feat by developing fluorescent duplexes capable of producing up to 16 million colors.

18 Oct 2023

Scientists Develop Novel Glycoengineering Platform to Revolutionize Vaccine and Therapeutic Production

A novel glycoengineering platform, created by the laboratory of Assistant Professor Chris Lok-To Sham from the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine), is poised to revolutionize future production of vaccines and therapeutics to fight infectious diseases.

17 Oct 2023

Research Offers a Promising Avenue for Improving T-Cell-Based Cancer Therapies

Using laboratory-grown cells from humans and genetically engineered mice, scientists at Johns Hopkins Medicine say they have evidence that modifying a specific protein in immune white blood cells known as CD8+ T cells can make the cells more robust, potentially opening the door for better use of people's own immune system T cells to fight cancer.

4 Oct 2023

New Synthetic Biology Approach Offers Promise for Treating Neurodegenerative Diseases

Researchers at the University of Cologne's CECAD Cluster of Excellence for Aging Research and the CEPLAS Cluster of Excellence for Plant Sciences have found a promising synthetic plant biology approach for the development of a therapy to treat human neurodegenerative diseases, especially Huntington's disease.

3 Oct 2023

New Insights into the Role of Intrinsically Disordered Regions in Chromatin Biology

According to textbooks, proteins work by folding into stable 3D shapes that, like Lego blocks, precisely fit with other biomolecules.

3 Oct 2023

How RNA Regulates Gene Silencing Could Pave Way for Novel Cancer Therapies

Deep inside our cells-;each one complete with an identical set of genes-;a molecular machine known as PRC2 plays a critical role in determining which cells become heart cells, versus brain or muscle or skin cells.

27 Sep 2023

Astrea Bioseparations Expands Manufacturing and Warehousing Capacity to Support Growing Demand for Its Chromatography Solutions in North America

Astrea Bioseparations announces the expansion of its manufacturing and warehousing capabilities in the US.

20 Sep 2023

Pre-Targeted Radioimmunotherapy System Cures Fatal Ovarian Cancer in Preclinical Study

A new 225Ac-DOTA-based pre-targeted radioimmunotherapy (PRIT) system has been shown to cure a highly lethal form of advanced intraperitoneal ovarian cancer in a preclinical setting with minimal side effects.

19 Sep 2023

LJI Scientists Harness 'Helper' T Cells To Treat Tumors

Scientists are on the hunt for a unique set of mutations, called "neoantigens," that let the immune system distinguish tumor cells from normal cells. Their goal is to help the immune system react to neoantigens and target tumor cells for destruction.

4 Sep 2023